BackCorbus Pharmaceuticals Holdings Overview
Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings Target Price

See Corbus Pharmaceuticals Holdings's analyst price targets ($36) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.08

Average Target Price

$36.25227.2% upside

4 analysts in the last 4 months

High: $44 | Low: $33

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-26H.C. Wainwright$35215.9% upsideOpen
2026-08-13Mizuho SecuritiesGraig Suvannavejh$33197.8% upsideOpen
2026-05-22Mizuho SecuritiesGraig Suvannavejh$44297.1% upsideOpen
2026-05-12JefferiesMaury Raycroft$33197.8% upsideOpen
2025-10-29Mizuho Securities$39252% upsideOpen
2025-10-20Piper Sandler$51360.3% upsideOpen
2025-10-20H.C. Wainwright$40261% upsideOpen
2024-12-02Piper SandlerBiren Amin$35215.9% upsideOpen
2024-10-21OppenheimerJeff Jones$60441.5% upsideOpen
2024-09-20B.Riley FinancialKalpit Patel$40261% upsideOpen
2024-09-13Mizuho SecuritiesGraig Suvannavejh$74567.9% upsideOpen
2024-08-07OppenheimerJeff Jones$88694.2% upsideOpen
2024-07-22H.C. WainwrightAndres Maldonado$80622% upsideOpen
2024-06-11RBC CapitalBrian Abrahams$82640.1% upsideOpen
2024-06-03OppenheimerJeff Jones$80622% upsideOpen
2024-05-20RBC CapitalBrian Abrahams$77594.9% upsideOpen
2024-03-06JefferiesMaury Raycroft$46315.2% upsideOpen

Corbus Pharmaceuticals Holdings (CRBP) FAQ

As of the most recent data, CRBP shows a target price of $36. Scroll down for historical charts and peer comparison views.

If Corbus Pharmaceuticals Holdings moved to the average analyst target of $36, shares would be roughly 227.2% higher than $11.08. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Corbus Pharmaceuticals Holdings's earnings trajectory.

Besides this target price page, Stockcircle has Corbus Pharmaceuticals Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $36) with ownership activity and broader fundamentals.

Corbus Pharmaceuticals Holdings's target price is $36; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.